Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Yana Dekempeneer actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
Onderzoeksoutput
-
Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer
Rodak, M., Dekempeneer, Y., Wojewódzka, M., Caveliers, V., Covens, P., Miller, B. W., Sevenois, M. B., Bruchertseifer, F., Morgenstern, A., Lahoutte, T., D'Huyvetter, M. & Pruszynski, M., 2 dec 2022, In: Molecular Cancer Therapeutics. 21, 12, blz. 1835-1845 11 blz.Onderzoeksoutput: Article › peer review
Open Access -
Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Breckpot, K., Devoogdt, N., Puttemans, J., De Veirman, K., Krasniqi, A., Ceuppens, H., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., Keyaerts, M., D'Huyvetter, M., Bruchertseifer, F. & Morgenstern, A., 6 dec 2022, (Accepted/In press) Journal of Nuclear Medicine.Onderzoeksoutput: Article › Specialist
-
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
Ertveldt, T., Dekempeneer, Y., De Beck, L., Goyvaerts, C., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 7 feb 2020, blz. page 79. 1 blz.Onderzoeksoutput: Unpublished abstract
Open AccessBestand7 Downloads (Pure) -
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
Puttemans, J., Dekempeneer, Y., Eersels, J. L., Hanssens, H., Debie, P., Keyaerts, M., Breckpot, K., Lecocq, Q., Lahoutte, T., Windhorst, A. D., Van Der Aa, F., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., 21 apr 2020, In: Cancers. 12, 4, 1017.Onderzoeksoutput: Article › peer review
Open AccessBestand27 Citaten (Scopus)243 Downloads (Pure) -
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Dekempeneer, Y., 2020Onderzoeksoutput: PhD Thesis
Prijzen
-
INCOVO Price Cancer Research
Dekempeneer, Yana (Recipient), dec 2016
Prijs: Prize (including medals and awards)
-
Junior Travel Grant TAT 2017
Dekempeneer, Yana (Recipient), 30 mrt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant EANM 2017
Dekempeneer, Yana (Recipient), 22 okt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant Research Stay Gothenburg
Dekempeneer, Yana (Recipient), 1 mei 2016
Prijs: Prize (including medals and awards)
Activiteiten
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor) & Yana Dekempeneer (Contributor)
2020Activiteit: Other
-
Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer (Speaker)
11 mei 2019Activiteit: Talk or presentation at a conference
-
11th International Symposium on Targeted-Alpha-Therapy
Yana Dekempeneer (Participant)
1 apr 2019 → 5 apr 2019Activiteit: Participation in conference
-
Combining bismuth-213 with Nanobodies: finding the match for Targeted Alpha Radionuclide Therapy
Yana Dekempeneer (Speaker)
1 apr 2019 → 5 apr 2019Activiteit: Talk or presentation at a conference
-
Research Stay Gothenburg
Yana Dekempeneer (Participant)
14 mei 2018 → 1 jun 2018Activiteit: Research and Teaching at External Organisation
Knipsels
-
-
Q&A: Treating cancer with precisely targeted drugs
3/02/17
1 item van Media-aandacht
Pers / media: !!Research
-
-
Jonge wetenschapster krijgt beurs: Yana onderzoekt of kamelen kanker kunnen helpen bestrijden (Het Nieuwsblad)
28/11/15
1 item van Media-aandacht
Pers / media: !!Research
-
Incovo steunt baanbrekend kankeronderzoek van jonge, Zemstse wetenschapper
14/12/16
1 item van Media-aandacht
Pers / media: !!Research
Scriptie
-
Radiolabeling of nanobodies with Bismuth-213 for Targeted Alpha Therapy
Auteur: Caveliers, V., Rens, L. & Dekempeneer, Y., 5 sep 2019Scriptie/Masterproef: Master's Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Cardinaels, T., Cornelissen, B., Flamen, P., Hernot, S., Ballet, S. & Breckpot, K., 2 sep 2020Begeleider: Caveliers, V. (Promotor), D'Huyvetter, M. (Promotor), Cardinaels, T. (Externe persoon) (Co-promotor), Cornelissen, B. (Externe persoon) (Jury), Flamen, P. (Jury), Ballet, S. (Jury), Hernot, S. (Jury) & Breckpot, K. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Ballet, S. & Dekempeneer, Y., sep 2020Begeleider: Ballet, S. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
TARGETED ALPHA THERAPY WITH SINGLE-DOMAIN ANTIBODY FRAGMENTS, A NOVEL CANCER TREATMENT
Auteur: Ballet, S. & Dekempeneer, Y., jun 2020Begeleider: Ballet, S. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
Towards a new, safe adjuvant: The effects of farnesyl pyrophosphate in the adaptive immune response
Auteur: De Kempeneer, Y., Annaert, W. & Liu, W., 2015Scriptie/Masterproef: Master's Thesis